Milani Alireza, Basirnejad Marzieh, Shahbazi Sepideh, Bolhassani Azam
Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Br J Pharmacol. 2017 Jun;174(11):1290-1324. doi: 10.1111/bph.13625. Epub 2016 Oct 29.
Carotenoids and retinoids have several similar biological activities such as antioxidant properties, the inhibition of malignant tumour growth and the induction of apoptosis. Supplementation with carotenoids can affect cell growth and modulate gene expression and immune responses. Epidemiological studies have shown a correlation between a high carotenoid intake in the diet with a reduced risk of breast, cervical, ovarian, colorectal cancers, and cardiovascular and eye diseases. Cancer chemoprevention by dietary carotenoids involves several mechanisms, including effects on gap junctional intercellular communication, growth factor signalling, cell cycle progression, differentiation-related proteins, retinoid-like receptors, antioxidant response element, nuclear receptors, AP-1 transcriptional complex, the Wnt/β-catenin pathway and inflammatory cytokines. Moreover, carotenoids can stimulate the proliferation of B- and T-lymphocytes, the activity of macrophages and cytotoxic T-cells, effector T-cell function and the production of cytokines. Recently, the beneficial effects of carotenoid-rich vegetables and fruits in health and in decreasing the risk of certain diseases has been attributed to the major carotenoids, β-carotene, lycopene, lutein, zeaxanthin, crocin (/crocetin) and curcumin, due to their antioxidant effects. It is thought that carotenoids act in a time- and dose-dependent manner. In this review, we briefly describe the biological and immunological activities of the main carotenoids used for the treatment of various diseases and their possible mechanisms of action.
This article is part of a themed section on Principles of Pharmacological Research of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc.
类胡萝卜素和视黄醇具有多种相似的生物学活性,如抗氧化特性、抑制恶性肿瘤生长和诱导细胞凋亡。补充类胡萝卜素可影响细胞生长并调节基因表达和免疫反应。流行病学研究表明,饮食中高类胡萝卜素摄入量与降低乳腺癌、宫颈癌、卵巢癌、结直肠癌以及心血管疾病和眼部疾病的风险之间存在关联。饮食中的类胡萝卜素对癌症的化学预防涉及多种机制,包括对间隙连接细胞间通讯、生长因子信号传导、细胞周期进程、分化相关蛋白、类视黄醇样受体、抗氧化反应元件、核受体、AP-1转录复合物、Wnt/β-连环蛋白途径和炎性细胞因子的影响。此外,类胡萝卜素可刺激B淋巴细胞和T淋巴细胞的增殖、巨噬细胞和细胞毒性T细胞的活性、效应T细胞功能以及细胞因子的产生。最近,富含类胡萝卜素的蔬菜和水果对健康有益并降低某些疾病风险的作用归因于主要的类胡萝卜素,如β-胡萝卜素、番茄红素、叶黄素、玉米黄质、藏红花素(/藏红花酸)和姜黄素,因其具有抗氧化作用。人们认为类胡萝卜素以时间和剂量依赖性方式发挥作用。在本综述中,我们简要描述了用于治疗各种疾病的主要类胡萝卜素的生物学和免疫学活性及其可能的作用机制。
本文是营养保健品药理学研究原理主题部分的一部分。要查看本部分的其他文章,请访问http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc。